Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

208.31
-2.0200-0.96%
Post-market: 208.580.2700+0.13%17:44 EST
Volume:7.49M
Turnover:1.57B
Market Cap:501.88B
PE:20.13
High:211.06
Open:209.80
Low:207.76
Close:210.33
52wk High:215.19
52wk Low:140.68
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.87
T/O Rate:0.31%
Dividend:5.08
Dividend Rate:2.44%
EPS(TTM):10.35
EPS(LYR):5.84
ROE:33.62%
ROA:8.26%
PB:6.33
PE(LYR):35.65

Loading ...

Perrigo Co. PLC Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Nov 05

Johnson & Johnson Unveils Promising New Blood Cancer Therapies at ASH 2025

Reuters
·
Nov 05

Johnson & Johnson Reports Strong One-Year Results for Shockwave Javelin Peripheral IVL Catheter

Reuters
·
Nov 05

RPT-BREAKINGVIEWS-A $40 bln deal for Tylenol trusts the M&A science

Reuters
·
Nov 04

AC Immune SA reports third quarter results and updates pipeline focus

Reuters
·
Nov 04

Press Release: AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Dow Jones
·
Nov 04

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Nov 04

New York Closing Stocks

Dow Jones
·
Nov 04

Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity

Benzinga_recent_news
·
Nov 04

Gold Edges Higher; ISM Manufacturing PMI Falls In October

Benzinga
·
Nov 04

Johnson & Johnson Reports Strong One-Year Results for Shockwave Peripheral IVL in Complex Below-the-Knee PAD

Reuters
·
Nov 04

Alvotech Shares Plunge 33% After FDA Flags Issues

Benzinga_recent_news
·
Nov 04

Kimberly-Clark Stock Heads for Biggest One-Day Drop Since Black Monday -- WSJ

Dow Jones
·
Nov 04

BUZZ-Alvotech drops after US FDA declines to approve arthritis drug

Reuters
·
Nov 03

BUZZ-Street View: Immunology strength holds at AbbVie despite aesthetics drag

Reuters
·
Nov 03

Press Release: Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

Dow Jones
·
Nov 03

Bristol Myers Squibb Presents New Long-Term and Real-World Data on Camzyos for Obstructive Hypertrophic Cardiomyopathy

Reuters
·
Nov 03

Johnson & Johnson Unveils New Pulsed Field Ablation Data for Atrial Fibrillation at APHRS and JPHRS

Reuters
·
Nov 03

Johnson & Johnson (JNJ): Is There More Value Ahead After a Steady Climb?

Simply Wall St.
·
Nov 02

Johnson & Johnson Seeks FDA Approval for STELARA in Pediatric Ulcerative Colitis

Reuters
·
Nov 01